When is ethics approval unethical?

Bioethics is an area of deep personal interest to me, and it is something that has challenged me many times in my entrepreneurial career. There are always opportunities to cut corners, to be “selective” with information, to be biased in decision making. Biomedical research and product development is tough because the dollars at stake are…

Novogen : Orphan Status for Dummies

My contempt for Novogen (ASX : NRT) is known, but today my contempt for Novogen shareholders is even greater than that of the company. Today, Novogen (ASX : NRT) received orphan designation for Anisina from the US Food and Drug Administration (FDA), with a resulting 20-odd% surge in share price. Whilst FDA orphan designation is nothing to…

The Muppet Show

I just can’t believe it. Even though my opinion about Benitec (ASX : BLT) and its management team is well known, and I was truly blown-away by the incredible announcement earlier this week of a pending NASDAQ IPO, I do actually want BLT to be successful. The cynical reader might find that hard to believe, but I…

Osprey Medical : Eagle or Turkey?

When I first started reading about Osprey Medical (ASX : OSP), I desperately wanted to find something good, to discover a small ASX-listed medtech company doing something great in the world. At a most basic level, there is a lot to like about OSP. It has some really good people. It seems to have¬†actually developed…